DE3781863D1 - Bordetella pertussis-polypeptide und toxinantigene. - Google Patents

Bordetella pertussis-polypeptide und toxinantigene.

Info

Publication number
DE3781863D1
DE3781863D1 DE8787850312T DE3781863T DE3781863D1 DE 3781863 D1 DE3781863 D1 DE 3781863D1 DE 8787850312 T DE8787850312 T DE 8787850312T DE 3781863 T DE3781863 T DE 3781863T DE 3781863 D1 DE3781863 D1 DE 3781863D1
Authority
DE
Germany
Prior art keywords
arg
thr
glu
tyr
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787850312T
Other languages
English (en)
Other versions
DE3781863T2 (de
Inventor
Tamas Bartfai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trion Forskning & Utveckling
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Application granted granted Critical
Publication of DE3781863D1 publication Critical patent/DE3781863D1/de
Publication of DE3781863T2 publication Critical patent/DE3781863T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8787850312T 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene. Expired - Fee Related DE3781863T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8604445A SE455946B (sv) 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner

Publications (2)

Publication Number Publication Date
DE3781863D1 true DE3781863D1 (de) 1992-10-29
DE3781863T2 DE3781863T2 (de) 1993-03-11

Family

ID=20365987

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787850312T Expired - Fee Related DE3781863T2 (de) 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene.

Country Status (12)

Country Link
US (1) US5225193A (de)
EP (1) EP0266325B1 (de)
JP (1) JP2635641B2 (de)
AT (1) ATE80895T1 (de)
AU (1) AU624066B2 (de)
DE (1) DE3781863T2 (de)
DK (1) DK312088A (de)
FI (1) FI891872A (de)
IE (1) IE872802L (de)
PT (1) PT85960B (de)
SE (1) SE455946B (de)
WO (1) WO1988002754A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279151B1 (de) * 1986-12-22 1993-04-28 Trion Forskning- Och Utvecklings Aktiebolag Pertussis-Toxin-Polypeptid und seine Applikationen
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
IT1229766B (it) * 1989-05-19 1991-09-10 Sclavo Spa Peptidi sintetici capaci di stimolare una immunita' t cellulare.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
SI3231444T1 (sl) 2014-05-12 2020-04-30 Verona Pharma Plc Novo zdravljenje

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質
JPS5767592A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein having reassociating properties and its preparation
JPS5767591A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein element substance and its preparation
JPS58222032A (ja) * 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
EP0279151B1 (de) * 1986-12-22 1993-04-28 Trion Forskning- Och Utvecklings Aktiebolag Pertussis-Toxin-Polypeptid und seine Applikationen
EP0362278A4 (de) * 1987-06-05 1990-05-14 Us Health Autokrine beweglichkeitsfaktoren bei der diagnose und behandlung von krebs.
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine

Also Published As

Publication number Publication date
IE872802L (en) 1988-04-20
AU8152487A (en) 1988-05-06
US5225193A (en) 1993-07-06
SE8604445D0 (sv) 1986-10-20
SE455946B (sv) 1988-08-22
DK312088A (da) 1988-08-10
WO1988002754A1 (en) 1988-04-21
FI891872A0 (fi) 1989-04-19
ATE80895T1 (de) 1992-10-15
PT85960B (pt) 1990-07-31
DE3781863T2 (de) 1993-03-11
JP2635641B2 (ja) 1997-07-30
FI891872A (fi) 1989-04-19
PT85960A (en) 1987-11-01
EP0266325A1 (de) 1988-05-04
EP0266325B1 (de) 1992-09-23
AU624066B2 (en) 1992-06-04
DK312088D0 (da) 1988-06-08
SE8604445L (sv) 1988-04-21
JPH02500977A (ja) 1990-04-05

Similar Documents

Publication Publication Date Title
NO901899D0 (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
DE3688246D1 (de) Kunstpolypeptide zum nachweis mykobakterieller infektionen.
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
DE3881204D1 (de) Molekuele mit mindestens einer peptidsequenz einer oder mehrerer epitopen eines p.falciparum-produzierten proteins in hepatozyten und zusammensetzungen davon.
DE3781863D1 (de) Bordetella pertussis-polypeptide und toxinantigene.
DE69018926D1 (de) Vakzine gegen Bordetella.
Gerencser et al. Serological identification of Actinomyces using fluorescent antibody techniques
DE69034254D1 (de) A-pdgf-rezeptor und dessen verwendung
DK232988D0 (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
ES2080955T3 (es) Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.
Foster et al. Serological and cellular immune responses to non‐structural proteins in animals infected with FMDV
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8904007D0 (sv) Monoklona antikroppar och diagnostiseringsmetod
Wiertz et al. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
ATE154846T1 (de) Satz zur schnellen aufzählung von granulocyten und verfahren das diesen satz verwendet
NO904129L (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
Messner et al. Alterations in isotypic and allotypic immunoglobulin antigens induced by chemical modification
Rice et al. Studies Of Johne's Disease In Canada: IX. Comparison of Complement-Fixation Titres Prior To and At 24 or 48 Hours After A Johnin Intradermal Test
GR1000377B (el) Νεα πρωτεινη αναγνωρισεως της κυησεως σε θηλαστικα εφαρμογες στην προωρη ανιχνευση της κυησεως και μεθοδος παρασκευης της εν λογω πρωτεινης.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee